Blepharitis refers to the inflammation of the eyelids which causes scaling or crusting of the eyelash line. It mainly occurs due to bacterial infection on the eyelids or due to dandruff-like flakes developing at the base of the eyelashes. The condition affects people of all ages however it is more commonly seen in middle-aged individuals. Blepharitis treatment involves eyelid scrubs, warm compresses, lid hygiene practices, and antibiotic or corticosteroid eye drops and ointments.
The global blepharitis treatment market is estimated to be valued at US$ 2.5 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030.
The blepharitis treatment market is driven by the rising prevalence of eye disorders across the globe. According to estimates, blepharitis affects nearly 25% of the population worldwide and leads to symptoms such as burning, irritation, conjunctivitis and blurry vision if left untreated. Furthermore, changing lifestyles, increase in screen time and growing geriatric population are contributing to the higher risk of developing eye problems. The treatment of blepharitis involves medications as well as procedures to remove loose skin and debris from the eyelids.
Key Takeaways
Key players operating in the blepharitis treatment market are Scope Ophthalmic Ltd., NovaBay Pharmaceuticals Inc., Thea Pharmaceuticals Ltd., Perrigo Laboratories, InSite Vision Incorporated, Merck & Co., and Novartis AG. The key players are focusing on expanding their product portfolios by developing novel drug formulations and treatment devices. For instance, in 2021, NovaBay Pharmaceuticals launched their prescription bleach eye spray NoveClenz for the treatment of blepharitis.
The rising awareness about blepharitis and availability of various treatment options are fueling the market growth. Furthermore, preference for minimally invasive procedures and in-office treatments for blepharitis is increasing among ophthalmologists as well as patients. This is encouraging new product launches by key players in the market.
Technological advancements are also supporting early diagnosis and treatment of blepharitis. For example, devices equipped with artificial intelligence and image analysis capabilities allow eye specialists to efficiently examine patients for tell-tale signs of blepharitis. This aids accurate diagnosis and timely intervention.
Market Trends
Increased adoption of at-home care products - There is higher demand for over-the-counter blepharitis treatment products such as warm compress kits, eyelid scrubs and hygiene solutions that can be conveniently used at home. This enables better treatment outcomes and symptom management.
Growing preference for minimally invasive procedures - Newer minimally invasive technologies such as intense pulsed light therapy, laser blepharoplasty and radiofrequency-assisted blepharoplasty are gaining popularity among patients and physicians due to benefits like reduced treatment time, lesser pain and lower risk of complications.
Market Opportunities
Development of combination therapies - Manufacturers can focus on developing combination products comprising antimicrobials, steroids and other active ingredients for enhanced blepharitis treatment. This will boost patient compliance and treatment effectiveness.
Geographical expansion into emerging markets - There is scope for key players to expand their presence in high growth regions like Asia Pacific and Latin America through collaborations, affordable product offerings and localized marketing initiatives. This can help address unmet needs in these underpenetrated markets.
Impact of COVID-19 on Blepharitis Treatment Market Growth
The COVID-19 pandemic has impacted the growth of the blepharitis treatment market. During the initial phases of the outbreak, several non-essential procedures and treatments were postponed to focus resources on combating the spread of the virus. This led to a decline in demand for blepharitis treatment drugs and therapies in 2020. However, as restrictions eased in 2021, the market witnessed a steady recovery.
Telemedicine emerged as an effective way to provide consultations and prescription refills to patients during lockdowns. This helped sustain revenues to some extent. Going forward, as in-person visits continue, the market is projected to demonstrate strong growth over the forecast period. Nevertheless, future waves of infections may pose challenges depending on their severity.
Pharmaceutical companies are focusing on developing more effective topical drugs and combination therapies to reduce dependence on eye procedures. This is expected to boost the market post-COVID. Additionally, government efforts to increase healthcare spending to strengthen systems will further support market growth in the long run.
Regional concentration and fastest growing regions for Blepharitis Treatment Market
In terms of value, North America dominates the blepharitis treatment market, accounting for over 40% share. This is attributed to rising blepharitis prevalence, growing geriatric population susceptible to the condition, availability of advanced treatment options and high healthcare expenditure levels in the region.
Asia Pacific is poised to emerge as the fastest growing market during the forecast period owing to improving access to healthcare, increasing patient awareness about eye diseases and rising discretionary incomes in developing countries such as India and China. Initiatives by pharmaceutical firms to launch generic alternatives suitable for Asia Pacific budgets are also aiding regional expansion.
Herbal Treatment for Blepharitis read the Symptoms and Causes.
Blepharitis is inflammation of the eyelids.
Blepharitis usually involves the part of the eyelid where the eyelashes grow and affect both eyelids.
Natural Treatment for Blepharitis is to maintain a good eyelid hygiene by washing the scalp. Natural Remedies for Blepharitis tips to help soothe your eyes back to good health.
According BMRC, Due to Covid-19 Effect next five years the Blepharitis market will register a 4.5%% CAGR in terms of revenue, Global market size will reach $ 1613.9 million by 2025, from $ 1353.8 million in 2019The Detailed market intelligence report on the Global Blepharitis Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Blepharitis Market place for the forecast 2020– 2026.Scope Of The Report:This Blepharitis market study specially analyses the impact of Covid-19 outbreak on the Blepharitis , covering the supply chain analysis, impact assessment to the market size growth rate in several scenarios, and the measures to be undertaken by companies in response to the COVID-19 epidemic.Get Sample Copy of This Premium Report: @ https://industrystatsreport.com/Request/Sample?ResearchPostId=13021=DownloadSampleReport evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors.
The complete knowledge is based on latest industry news, opportunities and trends.
The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region.
It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Blepharitis Market.Key Benefits for Blepharitis Market ReportsGlobal market report covers in-depth historical and forecast analysis.Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.Global market report helps to identify opportunities in market place.Global market report covers extensive analysis of emerging trends and competitive landscape.Blepharitis Market Segmentation By Types:Antibiotics, Steroids, OtherBlepharitis Market Segmentation By Application: MonOtherpy, Combination Drug TherapyBy RegionNorth America (U.S., Canada, Mexico)Europe (UK, France, Germany, Russia, Rest of Europe)Asia-Pacific( China, South Korea, India, Japan, Rest of Asia-Pacific)LAMEA (Latin America, Middle East, Africa)Blepharitis Market Key Players:Bausch Health, Allergan, LABORATORIES THEA, Akorn, Novartis, NovaBay Pharmaceuticals, Scope Ophthalmics, ...
This comprehensive report will provide:Enhance your strategic decision makingAssist with your research, presentations and business plansShow which emerging market opportunities to focus onIncrease your industry knowledgeKeep you up-to-date with crucial market developmentsAllow you to develop informed growth strategiesBuild your technical insightIllustrate trends to exploitStrengthen your analysis of competitorsProvide risk analysis, helping you avoid the pitfalls other companies could makeUltimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:Which are the driving factors responsible for the growth of market?Which are the roadblock factors of this market?What are the new opportunities, by which market will grow in coming years?What are the trends of this market?Which are main factors responsible for new product launch?How big is the global & regional market in terms of revenue, sales and production?How far will the market grow in forecast period in terms of revenue, sales and production?Which region is dominating the global market and what are the market shares of each region in the overall market in 2018?How will each segment grow over the forecast period and how much revenue will these segment account for in 2026?Which region has more opportunities?Get Full Report :@ https://industrystatsreport.com/Lifesciences-and-Healthcare/Blepharitis-Market-Industry-Report/Summary Other Related Reports:https://www.globenewswire.com/news-release/2020/11/24/2132548/0/en/At-CAGR-of-14-67-Contact-Center-Software-Market-Size-worth-38-83-Billion-by-2025-says-Brandessence-Market-Research.htmlhttps://www.globenewswire.com/news-release/2020/11/12/2125360/0/en/Home-Healthcare-Market-projected-to-exceed-293-6-billion-by-2026-Says-Brandessence-Market-Research.htmlAbout Us:Brandessence Market Research and Consulting Pvt.
Blepharitis is an ocular surface disease defined as inflammation of eyelid margins.
It is characterized as either anterior blepharitis or posterior blepharitis.
It can be controlled generally by off labels indication as currently there is no approved treatment for blepharitis.
The treatment available is comfortable for patients, preserving visual performance and preventing permanent damage to the ocular surface.
The common ramification of blepharitis includes hordeolum, chalazion (Styes) and blepharoconjunctivitis.Market Analysis: Global Blepharitis Drug MarketGlobal blepharitis drug market is rising gradually with a substantial CAGR in the forecast period of 2019-2026.
Growing population of blepharitis worldwide and emergence of drugs used in the treatment of risk associated with blepharitis such as blepharoconjunctivitis, hordeolum and chalazion (Styes) are the key factors to drive the market growth.Top Market Players:Few of the major competitors currently working in the global blepharitis drug market are AbbVie Inc., Amgen Inc, CELGENE CORPORATION, Pfizer Inc., Biogen, Novartis AG, Johnson & Johnson Services, Inc., Merck & Co., Inc., Regeneron Pharmaceuticals Inc., Gilead Sciences, Inc., Thea, NovaBay Pharmaceuticals, Inc, SCOPE PHARMA, Sun Pharmaceutical Industries Ltd, Galderma Laboratories, L.P., EyePoint Pharmaceuticals, Bausch Health., Nicox, Premark Pharma GmbH, Santen Pharmaceutical Co., Ltd and many others.Market DriversExposure to certain toxin or change in environment may increase the blepharitis diseasePrevalence of indoor as well as outdoor allergensIncrease in prevalence rate of blepharitis disease worldwideRising demand for advanced novel-targeted based therapiesMarket RestraintsEffective treatment is either unavailable or unaffordableInadequate knowledge about blepharitis disease in some developing countriesHigh cost involved in research and development for developing novel dosage formThe Detailed statistical analysis data is given or represented in Tabular format, Pie Charts, Graphs.
Blepharitis - Pipeline Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Blepharitis - Pipeline industry with a focus on the Chinese market.
The report provides key statistics on the market status of the Blepharitis - Pipeline manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Blepharitis - Pipeline market covering all important parameters.The key ponits of the report:The report provides a basic overview of the industry including its definition, applications and manufacturing technology.The report explores the international and Chinese major industry players in detail.
In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.Through the statistical analysis, the report depicts the global and Chinese total market of Blepharitis - Pipeline industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.The report then estimates 2019-2024 market development trends of Blepharitis - Pipeline industry.
Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.The report makes some important proposals for a new project of Blepharitis - Pipeline Industry before evaluating its feasibility.Critical Questions Addressed by the ReportWhat are the current trends that are driving the Blepharitis - Pipelinemarket?Where will all these developments take the industry in the mid- to long-term?Who are the top vendors in the Blepharitis - Pipelinemarket and what is their competitive analysis?How is adoption of Blepharitis - Pipelinesolutions among different industries?How is the adoption of Blepharitis - Pipelinesolutions among different regions?Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-blepharitis-pipeline-2019-2024-873There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.For competitor segment, the report includes global key players of Blepharitis - Pipeline as well as some small players.
GlaxoSmithKline Plc InMed Pharmaceuticals Inc. Karus Therpeutics Limited RegeneRx Biopharmaceuticals,Inc.The information for each competitor includes: Company Profile Main Business Information SWOT Analysis Sales, Revenue, Price and Gross Margin Market ShareFor product type segment, this report listed main product type of Blepharitis - Pipeline market in gloabal and china.
Product Type I Product Type II Product Type IIIFor end use/application segment, this report focuses on the status and outlook for key applications.
